Amlodipine Versus Nifedipine ER for the Management of Postpartum Hypertension

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 175 participants.

Also called NCT04790279

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 175 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT04790279
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT04790279. Randomized; no masking; primary purpose treatment. Start 2021-04-09 (actual); primary completion 2022-12-13 (actual). Results posted on 2024-10-28.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Amlodipine Versus Nifedipine ER for the Management of Postpartum Hypertension
Condition
Hypertension in Pregnancy
Intervention (Drug)
Amlodipine
Intervention (Drug)
NIFEdipine ER
Lead sponsor
Prisma Health-Upstate (class: other)

Record details

Record id
cardio:ct-nct04790279
Content hash
979780149ee58f69c29ef5c974940654de2551763eac76b0dd6abe96ec50e9e5